|
|||||
![]() |
|
Plant-based food and beverage company SunOpta (NASDAQ:STKL) announced better-than-expected revenue in Q1 CY2025, with sales up 9.3% year on year to $201.6 million. The company’s full-year revenue guidance of $796.5 million at the midpoint came in 0.7% above analysts’ estimates. Its non-GAAP profit of $0.04 per share was $0.03 above analysts’ consensus estimates.
Is now the time to buy STKL? Find out in our full research report (it’s free).
SunOpta’s first quarter results reflected steady volume-driven growth across its core categories, with management attributing the performance mainly to increased production capacity and customer demand in plant-based beverages, fruit snacks, and broth. CEO Brian Kocher emphasized, “Our top five customers delivered year-over-year growth in Q1,” and highlighted the company’s ability to unlock capacity in its manufacturing network, especially in the aseptic and fruit snacks facilities. While gross margin faced some pressure from investments in talent and temporary inefficiencies at the Midlothian plant, Kocher noted that the outperformance in the quarter was “more on the capacity creation side than the demand side,” underscoring the operational improvements that enabled SunOpta to fulfill rising customer orders.
Looking ahead, SunOpta’s updated guidance is built on expectations of continued category growth and a robust sales pipeline, which management says now represents approximately 25% of annual projected revenue. Kocher pointed to ongoing product and channel diversification as key factors supporting “a high degree of confidence in achieving our long-term revenue growth target of approximately 10%.” The company’s margin outlook hinges on further unlocking manufacturing capacity, improving production yields, and executing a four-point operational plan to drive sequential margin improvements throughout the year. CFO Greg Gaba cautioned that while tariffs are a fluid risk, SunOpta intends to pass through incremental tariff costs, stating, “We expect to substantially pass on all the incremental costs to our customers.”
Management tied first-quarter growth to expanded capacity and broad demand across its product portfolio, while highlighting operational initiatives and external factors shaping profitability.
SunOpta’s outlook is anchored by category growth, an expanding sales pipeline, and operational initiatives to improve margins and productivity.
In coming quarters, the StockStory team will track (1) the pace of gross margin expansion from ongoing operational initiatives, (2) progress on resolving the Midlothian facility bottleneck, and (3) sustained customer and category momentum reflected in pipeline conversion. Monitoring the effectiveness of SunOpta’s tariff pass-through strategy and its impact on both revenue and margin rates will also be important.
SunOpta currently trades at a forward P/E ratio of 29.8×. In the wake of earnings, is it a buy or sell? Find out in our full research report (it’s free).
Market indices reached historic highs following Donald Trump’s presidential victory in November 2024, but the outlook for 2025 is clouded by new trade policies that could impact business confidence and growth.
While this has caused many investors to adopt a "fearful" wait-and-see approach, we’re leaning into our best ideas that can grow regardless of the political or macroeconomic climate. Take advantage of Mr. Market by checking out our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
Jun-12 | |
Jun-06 | |
Jun-03 | |
May-28 | |
May-27 | |
May-27 | |
May-21 | |
May-18 | |
May-14 | |
May-08 | |
May-08 | |
May-07 | |
May-07 | |
May-07 | |
May-01 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite